San Diego Business Journal

Quidel Gets FDA OK for Flu Assay on Cepheid System

Friday, March 23, 2012

Quidel Corp. announced on March 22 that it received clearance from the Food and Drug Administration for its Quidel Molecular Influenza A+B Assay for the detection of influenza A and B for use with Cepheid’s SmartCycler PCR system.

Quidel received FDA clearance in December to run its Quidel Molecular Influenza A+B and hMPV assays on Life Technologies’ Applied Biosystems 7500 Fast DX thermocycler.